Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
CD19 CAR T细胞产品类型对复发或难治性侵袭性B细胞非霍奇金淋巴瘤预后的影响
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2021014497
Gauthier, Jordan; Gazeau, Nicolas; Hirayama, Alexandre V; Hill, Joshua A; Wu, Vicky; Cearley, Aisling; Perkins, Paula; Kirk, Angela; Shadman, Mazyar; Chow, Victor A; Gopal, Ajay K; Hodges Dwinal, Alexandria; Williamson, Staci; Myers, Jessie; Chen, Andy; Nagle, Sarah; Hayes-Lattin, Brandon; Schachter, Levanto; Maloney, David G; Turtle, Cameron J; Sorror, Mohamed L; Maziarz, Richard T
T细胞
T细胞
免疫/内分泌
B细胞
CD19
淋巴瘤
细胞生物学